Australian implantable cardiac defibrillator recipients: Quality-of-life issues

International Journal of Nursing Practice

Volumn 8, Issue 2, 2002, Pages 68-74

  Pelletier, Dianne ^a   Gallagher, Robyn ^a   Mitten Lewis, Suzanne ^a   McKinley, Sharon ^a   Squire, Jill ^b  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Driving; ICD; Quality of life; SF36; Shock experience

Indexed keywords

ADAPTIVE BEHAVIOR; ADOLESCENT; ADULT; AGED; ARTICLE; DEFIBRILLATOR; FEMALE; HEART ARRHYTHMIA; HUMAN; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; SICKNESS IMPACT PROFILE;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARRHYTHMIA; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; SICKNESS IMPACT PROFILE;

EID: 0036547335     PISSN: 13227114     EISSN: 1440172X     Source Type: Journal    
DOI: 10.1046/j.1440-172x.2002.00345.x     Document Type: Article

References (35)

1. Nisam S, Mower M. ICD trials: an extra ordinary means of determining patient risk. PACE 1998; 27: 1341-1346.
2. Cannom D. AVID and beyond lessons learned. Journal of Interventional Cardiology 1998; 11: 217-226.
3. Bocker D, Bansch D, Heinecke A et al. Potential benefit from implantable cardioverter-defibrillator therapy in patients with and without heart failure. Circulation 1998; 98: 1636-1643.
4. Morris MM, KenKnight BH, Warren JA, Lang DJ. A preview of the implantable cardioverter defibrillator systems in the next millennium: an integrative cardiac rhythm management approach. American Journal of Cardiology 1999; 83: D48-D54.
5. Brugada P, Brugada R, Geelen P. Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts. American Journal of Cardiology 1999; 83: 98.
6. Sticherling C, Klingenheben T, Cameron D, Hohnloser SH. Worldwide clinical experience with a down-sized active implantable defibrillator in 162 consecutive patients. PACE 1998; 21: 1778-1783.
7. Cannom D. A review of the implantable cardioverter defibrillator trials. Current Opinions in Cardiology 1998; 13: 3-8.
8. Park JK, Pollock ME. Use of the implantable cardioverter defibrillator in an eight month old infant with ventricular fibrillation arising from a myocardial fibroma. PACE 1999; 22: 138-141.
9. Gallagher R, McKinley S, Mangan B, Pelletier D, Squire J, Mitten-Lewis S.The impact of the implantable cardioverter defibrillator on quality of life. American Journal of Critical Care 1997; 6: 16-24.
10. Craney J, Mandle CL, Munro BH, Rankin S. Implantable cardioverter defibrillators. physical and psychosocial outcomes. American Journal of Critical Care 1997; 6: 445-451.
11. Bremner S, McCauley K, Axtell K. A follow-up study of patients with implantable cardioverter defibrillators. Journal of Cardiovascular Nursing 1993; 7: 40-51.
12. Reid S, McKinley S, Nagy S. Outcomes, problems and quality of life with the implantable cardioverter defibrillator. Australian Journal of Advances in Nursing 1999; 16: 14- 19.
13. May C, Smith P, Murdock C, Davis M. The impact of the implantable cardioverter defibrillator on quality-of-life. PACE 1995; 18: 1411-1418.
14. Pelletier D, Mitten-Lewis S, Gallagher R, McKinley S, Squire J. Implantable defibrillator recipients' responses to device implantation and design. Biomedical Instruments and Technology 1999; 33: 224-229.
15. Bainger E, Fernsler J. Perceived quality of life before and after implantation of an internal cardioverter defibrillator. American Journal of Critical Care 1995; 4: 36-43.
16. Pycha C, Calabrese J, Gulledge A, Maloney J. Patient and spouse acceptance and adaptation to implantable cardioverter-defibrillators. Cleveland Clinical Journal of Medicine 1990; 57: 441-444.
17. Sneed N, Finch N. Experiences of patients and significant others with automatic implantable cardioverter defibrillators after discharge from the hospital. Progress in Cardiovascular Nursing 1992; 7: 20-24.
18. Bolles Vitale M, Funk M. Quality of Life in younger persons with an implantable cardioverter defibrillator. Dimensions of Critical Care Nursing 1995; 14: 100-111.
19. Schuster P, Phillips S, Dillon D,Tomich P.The psychosocial and physiological experiences of patients with an implantable cardioverter defibrillator. Rehabilitation Nursing 1998; 23: 30-36.
20. Finch N, Sneed N, Lemon R,Watson J. Driving with an internal cardioverter defibrillator: legal ethical and quality of life issues. Journal of Cardiovascular Nursing 1997; 11: 58-67.
21. Dunbar S,Warner C, Purcell J. Internal cardioverter defibrillator device discharge: experiences of patients and family members. Heart and Lung:The Journal of Critical Care 1993; 22: 494-501.
22. Arteaga WJ, Drew BJ. Device therapy for ventricular tachycardia or fibrillation: the implantable cardioverter defibrillator and antitachycardia pacing. Critical Care Nursing 1991; 14: 60-71.
23. Molchany C, Peterson K.The psychosocial effects of support group intervention on AICD recipients and their significant others. Progress in Cardiovascular Nursing 1994; 9: 23-29.
24. Pinski S, Fahey GJ. Implantable cardioverter defibrillators. American Journal of Medicine 1999; 106: 446-458.
25. Olatidoye AG, Verroneau J, Kluger J. Mechanisms of syncope in implantable cardioverter defibrillator recipients who receive device therapies. American Journal of Cardiology 1998; 82: 1372-1376.
26. Bansch D, Brunn J, Castrucci M et al. Syncope in patients with an implantable cardioverter defibrillator - incidence predictions and implications for driving restrictions. American Journal of Cardiology 1998; 31: 8-615.
27. Craney JM, Powers MT. Factors related to driving in persons with an implantable cardioverter defibrillator. Progress in Cardiovascular Nursing 1995; 10: 12-17.
28. Keelan E, Dhala A, Axtell K et al. Driving habits and experiences of patients with implantable cardioverterdefibrillators. Journal of the American College of Cardiology 1995; 25.
29. Grimm W, Flores B, Marchlinski F. Complications of implantable cardioverter defibrillator therapy: follow-up of 241 patients. PACE 1993; 16: 218-222.
30. Herrmann C, von zur Muhen F, Schaumann A et al. Standardized assessment of psychological well-being and quality-of-life in patients with implanted defibrillators. PACE 1997; 20: 95-103.
31. Pfeiffer D, Jung W, Fehske W et al. Complications of pacemaker- defibrillator devices: diagnosis and management. American Heart Journal 1994; 127: 1073-1080.
32. Rosenqvist M, Beyer T, Block M, Dendulk K, Minten J, Lindemans F. Adverse events with transvenous implantable cardioverter defibrillators - a prospective multicenter study. Circulation 1998; 7: 663-670.
33. Hoffman E, Steinbeck G. Experience with pectoral versus abdominal implantation of a small defibrillator - a multicentre comparison in 778 patients. European Heart Journal 1998; 19: 1085-1098.
34. Lin M, Ward J. Reliability of MOS SF36 health status measure in Australian general practice. Australian Family Physician Supplement 1998; 2: S94-98.
35. Swygerman CA, Homoud M, Link M,Wang P, Estes N. Technologic advances in implantable cardioverter defibrillators. Current Opinions in Cardiology 1999; 14: 9-14.